rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving Carboplatin

Not Applicable

Completed

• Conditions: Neoplasms, Gynecologic
• Interventions: Drug: Thrombopoietin; Procedure: Platelet-pheresis; Drug: Carboplatin

• Registration Number: NCT00038012
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

A Pilot Study of Transfusion of rhTPO-Derived Autologous Platelets Cryopreserved with ThromboSol and 2% DMSO in Patients with Gynecologic Malignancy Receiving Carboplatin

Detailed Description

Not available

Study Timeline

• Study Start: 1999-07-23
• Study First Submitted: 2002-05-24
• Study First Submitted QC: 2002-05-24
• Study First Posted: 2002-05-27
• Primary Completion: 2004-06
• Study Completion: 2004-06
• Status Verified: 2018-10
• Last Update Submitted: 2018-10-30
• Last Update Posted: 2018-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 33

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
rhTPO-Derived Autologous Platelets Transfusion	Platelet-pheresis	-
rhTPO-Derived Autologous Platelets Transfusion	Thrombopoietin	-
rhTPO-Derived Autologous Platelets Transfusion	Carboplatin	-

Primary Outcome Measures

Name	Time	Method
Response Rate	Continuous

Trial Locations

Locations (1)

MD Anderson Cancer Center; 🇺🇸 Houston, Texas, United States